Nuveen’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26M Buy
1,744,334
+998,586
+134% +$10.7M 0.01% 1096
2026
Q1
$6.31M Buy
745,748
+13,795
+2% +$151K ﹤0.01% 1792
2025
Q4
$8.26M Buy
731,953
+355,614
+94% +$4.41M ﹤0.01% 1668
2025
Q3
$5.65M Sell
376,339
-69,321
-16% -$1.01M ﹤0.01% 1849
2025
Q2
$6.29M Sell
445,660
-466,918
-51% -$8.32M ﹤0.01% 1766
2025
Q1
$29.4M Sell
912,578
-6,657
-0.7% -$235K 0.01% 888
2024
Q4
$34.3M Buy
919,235
+326,636
+55% +$15.2M 0.01% 848
2024
Q3
$29.6M Buy
592,599
+7,462
+1% +$290K 0.01% 936
2024
Q2
$20.3M Buy
585,137
+66,260
+13% +$2.62M 0.01% 1123
2024
Q1
$28.4M Buy
518,877
+39,187
+8% +$1.94M 0.01% 945
2023
Q4
$20.5M Buy
479,690
+23,579
+5% +$733K 0.01% 1140
2023
Q3
$11.9M Buy
456,111
+47,786
+12% +$993K ﹤0.01% 1367
2023
Q2
$9.77M Sell
408,325
-83,426
-17% -$1.44M ﹤0.01% 1528
2023
Q1
$7.71M Sell
491,751
-347,053
-41% -$5.52M ﹤0.01% 1638
2022
Q4
$13.2M Buy
+838,804
New +$11.8M 0.01% 1312

Other funds holding BHVN

Nuveen's BHVN Position: Q2 2026 in Review

Nuveen increased its Biohaven (BHVN) stake by 134% in Q2 2026, buying an estimated $10.7M and bringing the position to 1,744,334 shares worth $26M. The position accounts for 0.01% of the portfolio, ranked #1096.

Nuveen first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $34.3M in Q4 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Nuveen held 1,744,334 shares of Biohaven worth $26M as of Q2 2026.
  • Nuveen bought 998,586 Biohaven shares in Q2 2026, an estimated $10.7M.
  • Biohaven made up 0.01% of Nuveen's portfolio in Q2 2026, its #1096 holding.
  • Nuveen first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Nuveen's Biohaven position peaked at $34.3M in Q4 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.